These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25775677)

  • 1. Gender-related long-term outcome of primary femoropopliteal stent placement for peripheral artery disease.
    Stavroulakis K; Donas KP; Torsello G; Osada N; Schönefeld E
    J Endovasc Ther; 2015 Feb; 22(1):31-7. PubMed ID: 25775677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN; Conrad MF; Guest JM; Hackney L; Patel VI; Kwolek CJ; Cambria RP
    J Vasc Surg; 2011 Oct; 54(4):1051-1057.e1. PubMed ID: 21636240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions.
    Piazza M; Squizzato F; Spolverato G; Milan L; Bonvini S; Menegolo M; Grego F; Antonello M
    J Vasc Surg; 2015 Nov; 62(5):1210-8.e1. PubMed ID: 26254822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
    Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
    J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis.
    Iida O; Soga Y; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M; Muramatsu T; Inoue N; Nanto S; Uematsu M
    J Endovasc Ther; 2011 Dec; 18(6):753-61. PubMed ID: 22149222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
    Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
    J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial.
    Rastan A; Krankenberg H; Baumgartner I; Blessing E; Müller-Hülsbeck S; Pilger E; Scheinert D; Lammer J; Beschorner U; Noory E; Neumann FJ; Zeller T
    J Endovasc Ther; 2015 Feb; 22(1):22-7. PubMed ID: 25775675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC; Cheng SW; Cheung GC
    J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.
    Grenville JL; Tan KT; Moshonov H; Rajan DK
    Vascular; 2015 Feb; 23(1):31-40. PubMed ID: 24695358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions.
    Gabrielli R; Rosati MS; Vitale S; Baciarello G; Siani A; Chiappa R; Caselli G; Irace L
    J Vasc Surg; 2012 Dec; 56(6):1598-605. PubMed ID: 23044257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
    Han DK; Shah TR; Ellozy SH; Vouyouka AG; Marin ML; Faries PL
    Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.
    Brouillet J; Deloose K; Goueffic Y; Poirier M; Midy D; Caradu C; Ducasse E
    J Cardiovasc Surg (Torino); 2018 Jun; 59(3):392-404. PubMed ID: 27272981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents.
    Schoenefeld E; Donas KP; Schönefeld T; Osada N; Austermann M; Torsello G
    Vasa; 2012 Jan; 41(1):49-56. PubMed ID: 22247060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years.
    Stavroulakis K; Torsello G; Manal A; Schwindt A; Hericks C; Stachmann A; Schönefeld E; Bisdas T
    J Vasc Surg; 2016 Dec; 64(6):1696-1702. PubMed ID: 27575816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.